You just read:

Rakuten Medical Releases New, Post-hoc Analysis of Safety, Pharmacokinetic (PK), Immunogenicity and Biomarker Data from its Phase 1 & 1/2a Clinical Trials

News provided by

Rakuten Medical, Inc.

Sep 30, 2019, 06:00 ET